Home Home Home Inbox Home Search

Event

Early Clinical Response of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by PORT Risk Class: Results from the OPTIC Study

Location: PACIFIC BALLROOM 22
Session Type: Mini Symposium
Tuesday
May
22
9:30 AM
9:45 AM

Speaker(s)/Author(s)

Amy Manley

BS
Paratek Pharmaceuticals

Evan Tzanis

BS
Paratek Pharmaceuticals

Julio Alberto. Ramirez

MD, FACP
Univ of Louisville;University of Louisville

Paul McGovern

MD
Paratek Pharmaceuticals

Paul B. Eckburg

MD
Paratek Pharmaceuticals

Anita Das

PhD
Paratek Pharmaceuticals

Courtney Kirsch

BS
Paratek Pharmaceuticals

Lynne Garrity-Ryan

PhD
Paratek Pharmaceuticals

View Abstract

Early Clinical Response of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by PORT Risk Class: Results from the OPTIC Study

Parent Sessions

  • C17 - NEW INSIGHTS IN ACUTE PULMONARY INFECTIONS...
    05-22-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search